572.3000 -6.80 (-1.17%)
NSE Jun 24, 2026 15:31 PM
Volume: 248.4K
 

572.30
-1.17%
Axis Direct
We expect gross margins to be impacted due to an increase in revenue share from the non-regulated market going onwards, therefore recommend HOLD' with a target price of Rs 1,670/share (PE 20x for FY23EPS).
Solara Active Pharma has gained 31.78% in the last 3 Months
More from Solara Active Pharma Sciences Ltd.
Recommended